Dianthus Therapeutics | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Adcock Ingram Holdings ZAR 89.42M 17.72M 2024-06
Alaunos Therapeutics USD 1.68M 780K 2024-09
Avita Medical AUD 14.05M 3.4M 2024-12
Celltrion KRW 972.66B 68.24B 2024-09
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 33.67M 280.5M 2024-09
Ecofibre AUD 6.74M 4.89M 2024-06
IQVIA Holdings USD 1.7B 130M 2024-12
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 44.58M 31.49M 2024-06
Malin Corporation EUR 35.7M 6.4M 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Moderna USD 1.93B 283M 2024-12
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Organigram Holdings 79.26M 7.45M 2024-06
Organon & Co USD 675M 88M 2024-12
Pharma Mar EUR 63.24M 28.44M 2024-12
Qiagen NV USD 663.56M 309.42M 2024-12
Revvity USD 1.16B 66.38M 2024-12
Sartorius EUR 579.2M 12M 2024-09
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Tectonic Therapeutic USD 159.1M 26.03M 2024-09
Tilray USD 189.7M 15.49M 2024-11
Viatris USD 734.8M 1.14B 2024-12
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12
Zz Pientze Pharmaceu 3.27B 895.19M 2024-09



Dianthus Therapeutics Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.